117 related articles for article (PubMed ID: 24450684)
1. Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.
Paidpally V; Mercier G; Shah BA; Senthamizhchelvan S; Subramaniam RM
AJR Am J Roentgenol; 2014 Feb; 202(2):406-12. PubMed ID: 24450684
[TBL] [Abstract][Full Text] [Related]
2. FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors.
Sridhar P; Mercier G; Tan J; Truong MT; Daly B; Subramaniam RM
AJR Am J Roentgenol; 2014 May; 202(5):1114-9. PubMed ID: 24758668
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
[TBL] [Abstract][Full Text] [Related]
4. Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.
Shah B; Srivastava N; Hirsch AE; Mercier G; Subramaniam RM
Ann Nucl Med; 2012 Nov; 26(9):707-14. PubMed ID: 22797818
[TBL] [Abstract][Full Text] [Related]
5. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
Sahiner I; Atasever T; Akdemir UO; Ozturk C; Memis L
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):357-63. PubMed ID: 23747221
[TBL] [Abstract][Full Text] [Related]
6. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
7. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
8. Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
Viner M; Mercier G; Hao F; Malladi A; Subramaniam RM
Radiology; 2013 May; 267(2):596-601. PubMed ID: 23297330
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
Kurtipek E; Çayci M; Düzgün N; Esme H; Terzi Y; Bakdik S; Aygün MS; Unlü Y; Burnik C; Bekci TT
Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234
[TBL] [Abstract][Full Text] [Related]
12. Variations in (18)F-FDG uptake in breast cancer depending on PET/CT acquisition position.
Lee JH; Jeon TJ; Ahn SG; Jeong J; Seok JW; Ryu YH
Clin Radiol; 2016 Jan; 71(1):86-91. PubMed ID: 26646369
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of (18)F-FDG PET/CT metabolic parameters in metastatic differentiated thyroid cancers.
Masson-Deshayes S; Schvartz C; Dalban C; Guendouzen S; Pochart JM; Dalac A; Fieffe S; Bruna-Muraille C; Dabakuyo-Yonli TS; Papathanassiou D
Clin Nucl Med; 2015 Jun; 40(6):469-75. PubMed ID: 25899591
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
Zhang C; Liao C; Penney BC; Appelbaum DE; Simon CA; Pu Y
Radiology; 2015 Jun; 275(3):862-9. PubMed ID: 25584710
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
20. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
